Table 3 Therapeutic effects in the botulinum toxin group
Botulinum toxin group | Adult group (n=31) | Children group (n=9) | Total (n=40) | Chi square or t value | P value |
|---|---|---|---|---|---|
Success cases for injection episode | |||||
Frist injection (Number, %) | 21 (67.7%) | 8 (88.8%) | 29 (72.5%) | / | 0.41 |
Second injection (Number,%) | 8 (25.8%) | 1 (11.1%) | 9 (22.5%) | ||
Third injection (Number,%) | 0 (0%) | 0 (0%) | 0 (0%) | ||
Cumulative Initial success cases (Number,%) | 29 (93.5%) | 9 (100%) | 38 (95%) | / | 1.0 |
Relapse cases (Number,%) | 9 (29.0%) | 0 (0%) | 9 (22.5%) | / | 0.09 |
Final success cases (Number,%) | 20 (64.5%) | 9 (100%) | 29 (72.5%) | / | 0.04 |
Esophoria cases (Number,%) | 18 (58.0%) | 3(33.3%) | 21 (52.5%) | / | 0.26 |
Deviation at six month (PD) | 6.12 ± 1.91 | 3.55 ± 3.60 | 5.53 ± 2.52 | -2.86 | 0.007 |
Deviation at final follow-up (PD) | 6.80 ± 1.88 | 4.22 ± 3.30 | 5.96 ±2.65 | -3.01 | 0.005 |
Follow-up time (Months) | 20.0 ± 8.64 | 15.1 ± 8.76 | 17.4 ± 5.64 | -1.49 | 0.14 |